Cargando…

A Phase Ib study of neoadjuvant immune biomarker modulation with cetuximab and motolimod in head and neck cancer (HNC)

Detalles Bibliográficos
Autores principales: Ferris, Robert L, Kansy, Benjamin A, Gibson, Sandra Poveda, Srivastava, Raghvendra M, Bryan, James Kyle, Hershberg, Robert M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645263/
http://dx.doi.org/10.1186/2051-1426-3-S2-P144
_version_ 1782400795506900992
author Ferris, Robert L
Kansy, Benjamin A
Gibson, Sandra Poveda
Srivastava, Raghvendra M
Bryan, James Kyle
Hershberg, Robert M
author_facet Ferris, Robert L
Kansy, Benjamin A
Gibson, Sandra Poveda
Srivastava, Raghvendra M
Bryan, James Kyle
Hershberg, Robert M
author_sort Ferris, Robert L
collection PubMed
description
format Online
Article
Text
id pubmed-4645263
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46452632015-11-20 A Phase Ib study of neoadjuvant immune biomarker modulation with cetuximab and motolimod in head and neck cancer (HNC) Ferris, Robert L Kansy, Benjamin A Gibson, Sandra Poveda Srivastava, Raghvendra M Bryan, James Kyle Hershberg, Robert M J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4645263/ http://dx.doi.org/10.1186/2051-1426-3-S2-P144 Text en Copyright © 2015 Ferris et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Ferris, Robert L
Kansy, Benjamin A
Gibson, Sandra Poveda
Srivastava, Raghvendra M
Bryan, James Kyle
Hershberg, Robert M
A Phase Ib study of neoadjuvant immune biomarker modulation with cetuximab and motolimod in head and neck cancer (HNC)
title A Phase Ib study of neoadjuvant immune biomarker modulation with cetuximab and motolimod in head and neck cancer (HNC)
title_full A Phase Ib study of neoadjuvant immune biomarker modulation with cetuximab and motolimod in head and neck cancer (HNC)
title_fullStr A Phase Ib study of neoadjuvant immune biomarker modulation with cetuximab and motolimod in head and neck cancer (HNC)
title_full_unstemmed A Phase Ib study of neoadjuvant immune biomarker modulation with cetuximab and motolimod in head and neck cancer (HNC)
title_short A Phase Ib study of neoadjuvant immune biomarker modulation with cetuximab and motolimod in head and neck cancer (HNC)
title_sort phase ib study of neoadjuvant immune biomarker modulation with cetuximab and motolimod in head and neck cancer (hnc)
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645263/
http://dx.doi.org/10.1186/2051-1426-3-S2-P144
work_keys_str_mv AT ferrisrobertl aphaseibstudyofneoadjuvantimmunebiomarkermodulationwithcetuximabandmotolimodinheadandneckcancerhnc
AT kansybenjamina aphaseibstudyofneoadjuvantimmunebiomarkermodulationwithcetuximabandmotolimodinheadandneckcancerhnc
AT gibsonsandrapoveda aphaseibstudyofneoadjuvantimmunebiomarkermodulationwithcetuximabandmotolimodinheadandneckcancerhnc
AT srivastavaraghvendram aphaseibstudyofneoadjuvantimmunebiomarkermodulationwithcetuximabandmotolimodinheadandneckcancerhnc
AT bryanjameskyle aphaseibstudyofneoadjuvantimmunebiomarkermodulationwithcetuximabandmotolimodinheadandneckcancerhnc
AT hershbergrobertm aphaseibstudyofneoadjuvantimmunebiomarkermodulationwithcetuximabandmotolimodinheadandneckcancerhnc
AT ferrisrobertl phaseibstudyofneoadjuvantimmunebiomarkermodulationwithcetuximabandmotolimodinheadandneckcancerhnc
AT kansybenjamina phaseibstudyofneoadjuvantimmunebiomarkermodulationwithcetuximabandmotolimodinheadandneckcancerhnc
AT gibsonsandrapoveda phaseibstudyofneoadjuvantimmunebiomarkermodulationwithcetuximabandmotolimodinheadandneckcancerhnc
AT srivastavaraghvendram phaseibstudyofneoadjuvantimmunebiomarkermodulationwithcetuximabandmotolimodinheadandneckcancerhnc
AT bryanjameskyle phaseibstudyofneoadjuvantimmunebiomarkermodulationwithcetuximabandmotolimodinheadandneckcancerhnc
AT hershbergrobertm phaseibstudyofneoadjuvantimmunebiomarkermodulationwithcetuximabandmotolimodinheadandneckcancerhnc